Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

SheppHeartCABG trial-comprehensive early rehabilitation after coronary artery bypass grafting: a protocol for a randomised clinical trial

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


  1. Asthma severity and fertility outcome in women with polycystic ovary syndrome: a registry-based study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. FeNO-based asthma management results in faster improvement of airway hyperresponsiveness

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Sharing and reuse of individual participant data from clinical trials: principles and recommendations

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Early vasopressor use following traumatic injury: a systematic review

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Spousal bereavement after fibrotic interstitial lung disease: A qualitative study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Interventions for preventing intensive care unit delirium in adults

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

Vis graf over relationer

INTRODUCTION: Patients undergoing coronary artery bypass graft surgery often experience a range of symptoms. Studies indicate that non-pharmacological interventions such as exercise training and psychoeducation have a positive physiological and psychological effect in early outpatient rehabilitation. The SheppHeartCABG trial will investigate the effect of early comprehensive rehabilitation in early phase rehabilitation versus usual care. The aim of this paper is to present the protocol for the SheppHeartCABG trial.

METHODS/ANALYSIS: SheppHeartCABG is an investigator-initiated randomised clinical superiority trial with blinded outcome assessment, employing 1:1 central randomisation to rehabilitation plus usual care versus usual care alone. On the basis of a sample size calculation, 326 patients undergoing coronary artery bypass grafting will be included from two clinical sites. All patients receive usual care and patients allocated to the experimental intervention follow 4 weeks rehabilitation consisting of an exercise programme, psycho-educative consultations and a compact mindfulness programme. The primary outcome is physical function measured by the 6-min walk test. The secondary outcomes are mental health and physical activity measured by the Medical Outcome Study Short Form (SF-12), anxiety and depression measured by the Hospital Anxiety and Depression Scale questionnaire, physical, emotional and global scores by the HeartQoL questionnaire, sleep measured by the Pittsburgh Sleep Quality Index, pain measured by the Örebro Musculoskeletal Screening Questionnaire and muscle endurance measured by the sit-to-stand test. A number of explorative analyses will also be conducted.

ETHICS AND DISSEMINATION: SheppHeartCABG is approved by the regional ethics committee (no. H-4-2014-109) and the Danish Data Protection Agency (no. 30-1309) and is performed in accordance with good clinical practice and the Declaration of Helsinki in its latest form. Positive, neutral and negative results of the trial will be submitted to international peer-reviewed journals. Furthermore, results will be presented at national and international conferences relevant to the subject fields.

TRIAL REGISTRATION NUMBER: NCT02290262; pre-results.

TidsskriftB M J Open
Sider (fra-til)e013038
StatusUdgivet - 17 jan. 2017

ID: 49706568